These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 8739864)

  • 1. Effect of systemically administered H1- and H2-receptor antagonists on nasal blood flow as measured with laser Doppler flowmetry in a provoked allergic reaction.
    Juliusson S; Bende M
    Rhinology; 1996 Mar; 34(1):24-7. PubMed ID: 8739864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of fexofenadine on the early response to nasal allergen challenge.
    Allocco FT; Votypka V; deTineo M; Naclerio RM; Baroody FM
    Ann Allergy Asthma Immunol; 2002 Dec; 89(6):578-84. PubMed ID: 12487223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of H1- and H2-antihistamines on platelet-activating factor and bradykinin-induced inflammatory responses in human skin.
    Sansom JE; Brooks J; Burton JL; Archer CB
    Clin Exp Dermatol; 1996 Jan; 21(1):33-7. PubMed ID: 8689766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mizolastine and fexofenadine modulate cytokine pattern after nasal allergen challenge.
    Ciprandi G; Cirillo I; Vizzaccaro A
    Eur Ann Allergy Clin Immunol; 2004 Apr; 36(4):146-50. PubMed ID: 15180356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The activity of recent anti-allergic drugs in the treatment of seasonal allergic rhinitis.
    Wang D; Clement P; Smitz J; De Waele M
    Acta Otorhinolaryngol Belg; 1996; 50(1):25-32. PubMed ID: 8669268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Terfenadine, an H1 antihistamine, inhibits histamine release in vivo in the human.
    Naclerio RM; Kagey-Sobotka A; Lichtenstein LM; Freidhoff L; Proud D
    Am Rev Respir Dis; 1990 Jul; 142(1):167-71. PubMed ID: 1695070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of topical treatment with H1 and H2 antagonists on clinical symptoms and nasal vascular reactions in patients with allergic rhinitis.
    Holmberg K; Pipkorn U; Bake B; Blychert LO
    Allergy; 1989 May; 44(4):281-7. PubMed ID: 2567579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of terfenadine and budesonide on nasal symptoms, olfaction, and nasal airway patency following allergen challenge.
    Hilberg O
    Allergy; 1995 Aug; 50(8):683-8. PubMed ID: 7503405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting adenosine receptors in the treatment of allergic rhinitis: a randomized, double-blind, placebo-controlled study.
    Rimmer J; Peake HL; Santos CM; Lean M; Bardin P; Robson R; Haumann B; Loehrer F; Handel ML
    Clin Exp Allergy; 2007 Jan; 37(1):8-14. PubMed ID: 17210036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A placebo-controlled evaluation of butterbur and fexofenadine on objective and subjective outcomes in perennial allergic rhinitis.
    Lee DK; Gray RD; Robb FM; Fujihara S; Lipworth BJ
    Clin Exp Allergy; 2004 Apr; 34(4):646-9. PubMed ID: 15080820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in airway inflammation following nasal allergic challenge in patients with seasonal rhinitis.
    Bonay M; Neukirch C; Grandsaigne M; Leçon-Malas V; Ravaud P; Dehoux M; Aubier M
    Allergy; 2006 Jan; 61(1):111-8. PubMed ID: 16364165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind controlled crossover study comparing the protective effect of picumast dihydrochloride versus placebo following nasal allergen challenge.
    Franke W; Bachert C; Messinger D
    Arzneimittelforschung; 1989 Oct; 39(10A):1354-6. PubMed ID: 2576362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do the leukotriene receptor antagonists work in children with grass pollen-induced allergic rhinitis?
    Keskin O; Alyamac E; Tuncer A; Dogan C; Adalioglu G; Sekerel BE
    Pediatr Allergy Immunol; 2006 Jun; 17(4):259-68. PubMed ID: 16771779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of single or combined histamine H1-receptor and leukotriene CysLT1-receptor antagonism on nasal adenosine monophosphate challenge in persistent allergic rhinitis.
    Lee DK; Jackson CM; Soutar PC; Fardon TC; Lipworth BJ
    Br J Clin Pharmacol; 2004 Jun; 57(6):714-9. PubMed ID: 15151516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nasal allergic response mediated by histamine H3 receptors in murine allergic rhinitis.
    Nakaya M; Fukushima Y; Takeuchi N; Kaga K
    Laryngoscope; 2005 Oct; 115(10):1778-84. PubMed ID: 16222194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of intranasally applied dimethindene maleate solution as spray in adult volunteers with symptoms of seasonal allergic rhinitis in the Vienna challenge chamber.
    Kyrein HJ; Horak F; Nirnberger G; Rehn D
    Arzneimittelforschung; 1996 Aug; 46(8):794-9. PubMed ID: 9125281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the cutaneous response to histamine by H1-blocking agents. Quantitative evaluation of microvascular changes in the skin after histamine challenge and a comparison of the effects of a single intake of cetirizine and terfenadine.
    Van Neste D; Rihoux JP
    Skin Pharmacol; 1988; 1(3):192-9. PubMed ID: 2908486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of kinins in seasonal allergic rhinitis: icatibant, a bradykinin B2 receptor antagonist, abolishes the hyperresponsiveness and nasal eosinophilia induced by antigen.
    Turner P; Dear J; Scadding G; Foreman JC
    J Allergy Clin Immunol; 2001 Jan; 107(1):105-13. PubMed ID: 11149999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasal challenge with allergen leads to maxillary sinus inflammation.
    Baroody FM; Mucha SM; Detineo M; Naclerio RM
    J Allergy Clin Immunol; 2008 May; 121(5):1126-1132.e7. PubMed ID: 18367240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histamine releasability after adenosine challenge in subjects with allergic and non-allergic rhinitis: possible implications for mast cell priming.
    Polosa R; Pagano C; Low JL; Church MK; Crimi N
    Ann Ital Med Int; 1999; 14(2):86-93. PubMed ID: 10399370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.